DAHL v. HEM PHARMACEUTICALS CORP.

No. 94 CIV 563 AGS.

867 F.Supp. 194 (1994)

Kristina A. DAHL, Plaintiff, v. HEM PHARMACEUTICALS CORP. in care of Prentice Hall Corp. Systems, Inc., f/k/a HEM Research, Inc. and HEM Pharmaceuticals, Inc., Defendant.

United States District Court, S.D. New York.

October 26, 1994.


Attorney(s) appearing for the Case

Stein & Associates, P.C., New York City, for plaintiff.

Choate, Hall & Stewart, Boston, MA, for defendant.


ORDER

SCHWARTZ, District Judge:

This is a diversity action that was removed by defendant from New York State Supreme Court. The Complaint alleges two causes of action arising out of plaintiff's participation in a medical clinical trial of an experimental pharmaceutical compound manufactured by defendant called Ampligen, which is used for the treatment of Chronic Fatigue Immune Dysfunction Syndrome ("CFIDS"). The first cause of action is for lack of...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases